老虎证券

BRIEF-FDA Says Bard Peripheral Vascular Issued Letter To Affected Customers On Rotarex Atherectomy Systems Usage

Reuters
03-21
BRIEF-FDA Says Bard Peripheral Vascular Issued Letter To Affected Customers On Rotarex Atherectomy Systems Usage

March 20 (Reuters) - FDA:

  • FDA: AWARE BARD PERIPHERAL VASCULAR ISSUED LETTER TO AFFECTED CUSTOMERS PROVIDING UPDATED INSTRUCTIONS FOR USE FOR ROTAREX ATHERECTOMY SYSTEMS

  • FDA: IDENTIFIED BARD PERIPHERAL VASCULAR'S ATHERECTOMY CATHETER SYSTEM RECALL AS THE MOST SERIOUS TYPE

  • FDA: BD REPORTED 30 SERIOUS INJURIES, 4 DEATHS ASSOCIATED WITH ATHERECTOMY CATHETER SYSTEM ISSUE FROM BARD PERIPHERAL VASCULAR

  • FDA: BD REPORTED 115 CASES REQUIRING ADDITIONAL INTERVENTION FOLLOWING HELIX FRACTURE AND/OR BREAKAGE RELATED TO ATHERECTOMY CATHETER SYSTEM ISSUE

(((( Reuters.Briefs@thomsonreuters.com ;));))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10